Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials
Số trang: 11
Loại file: pdf
Dung lượng: 601.40 KB
Lượt xem: 8
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Fluticasone furoate (FF)/vilanterol (VI) is a once daily (OD) inhaled corticosteroid/long-acting β2-agonist combination asthma therapy approved in Japan and the EU. FF/VI efficacy and safety data from asthma studies including patients in East Asia were evaluated to assess ethnic sensitivity.
Nội dung trích xuất từ tài liệu:
Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials
Nội dung trích xuất từ tài liệu:
Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials
Tìm kiếm theo từ khóa liên quan:
BMC Pulmonary Medicine β2-adrenergic receptor agonists Treatment outcome Fluticasone furoate Asthma therapyTài liệu có liên quan:
-
Quality of life is associated with physical activity and fitness in cystic fibrosis
9 trang 30 0 0 -
Clinical impact of cardiovascular disease on patients with bronchiectasis
7 trang 30 0 0 -
7 trang 30 0 0
-
7 trang 30 0 0
-
11 trang 29 0 0
-
9 trang 29 0 0
-
Efect of periodontal therapy on COPD outcomes: A systematic review
16 trang 25 0 0 -
10 trang 25 0 0
-
8 trang 24 0 0
-
9 trang 23 0 0